ADMP inhibitors represent a specialized class of chemical compounds that target and modulate the activity of the protein ADMP (Anti-Dorsalizing Morphogenetic Protein), a member of the TGF-beta superfamily. This protein is involved in complex biochemical pathways, particularly in the regulation of developmental processes. By interacting with ADMP, these inhibitors are able to impact specific cellular signaling mechanisms, particularly those associated with morphogenetic gradients and developmental patterning. The intricate role of ADMP in modulating the balance between various growth factors like BMP (Bone Morphogenetic Protein) and other signaling molecules makes ADMP inhibitors valuable tools for investigating developmental biology and embryogenesis. They serve as molecular probes to delineate how ADMP exerts its effects on different developmental axes, such as the dorsal-ventral axis in vertebrates.
Chemically, ADMP inhibitors are diverse, often characterized by their ability to bind specific active sites or regulatory domains on the ADMP molecule. This binding disrupts the protein's interactions with other components of morphogenetic signaling pathways, thereby influencing cellular differentiation, proliferation, and apoptosis during critical stages of development. The structural diversity of ADMP inhibitors often includes small molecules or peptidomimetics that are engineered for high affinity and specificity to ADMP's active regions. Detailed biochemical studies of these inhibitors have provided insights into the conformational changes and molecular interactions necessary for ADMP's regulatory function. By inhibiting ADMP activity, these compounds offer a method to control or observe changes in the signaling dynamics that underlie the formation of complex tissue structures and patterning during development.
VEDI ANCHE...
| Nome del prodotto | CAS # | Codice del prodotto | Quantità | Prezzo | CITAZIONI | Valutazione |
|---|---|---|---|---|---|---|
4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline | 1062368-24-4 | sc-476297 | 5 mg | $240.00 | ||
Piccola molecola inibitrice dei recettori BMP di tipo I, potenzialmente in grado di influenzare la segnalazione legata alle ADMP. | ||||||
DMH-1 | 1206711-16-1 | sc-361171 sc-361171B sc-361171A sc-361171C | 10 mg 25 mg 50 mg 100 mg | $209.00 $312.00 $620.00 $1026.00 | 2 | |
Inibitore selettivo del recettore BMP, potrebbe avere un impatto sulle vie di segnalazione che coinvolgono ADMP. | ||||||
Dorsomorphin dihydrochloride | 1219168-18-9 | sc-361173 sc-361173A | 10 mg 50 mg | $182.00 $736.00 | 28 | |
Inibisce la segnalazione delle BMP, colpendo i recettori delle BMP di tipo I, influenzando potenzialmente l'attività delle ADMP. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $80.00 $212.00 $408.00 | 48 | |
Inibisce le chinasi di tipo I del recettore dell'attivina della superfamiglia TGF-β, può influenzare i processi legati all'ADMP. | ||||||
SB-505124 | 694433-59-5 | sc-362794 sc-362794A | 10 mg 50 mg | $321.00 $1350.00 | 2 | |
Inibisce ALK4, ALK5 e ALK7, parte della segnalazione del TGF-β, con potenziale impatto sulla funzione dell'ADMP. | ||||||
A 83-01 | 909910-43-6 | sc-203791 sc-203791A | 10 mg 50 mg | $198.00 $650.00 | 16 | |
Inibisce ALK5, ALK4 e ALK7, può influenzare indirettamente le vie che coinvolgono ADMP. | ||||||
ALK5 Inhibitor II | 446859-33-2 | sc-221234 sc-221234A sc-221234B sc-221234C sc-221234D sc-221234E sc-221234F | 1 mg 5 mg 10 mg 50 mg 100 mg 500 mg 1 g | $75.00 $150.00 $215.00 $650.00 $1224.00 $4296.00 $7818.00 | 8 | |
Inibisce il recettore ALK5 del TGF-β, influenzando potenzialmente la segnalazione legata all'ADMP. | ||||||